BioXcel Therapeutics (BTAI) Reiterated at Buy by Truist, Continue to see 701 as Monetizable Opportunity

Go back to BioXcel Therapeutics (BTAI) Reiterated at Buy by Truist, Continue to see 701 as Monetizable Opportunity
(NASDAQ: BTAI) Delayed: 1.07 +0.01 (0.94%)
Previous Close $1.06    52 Week High
Open $1.10    52 Week Low
Day High $1.14    P/E N/A 
Day Low $1.05    EPS
Volume 469,906